Harrow Health, Inc. (HROW)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$40.45
-2.32%
Mkt Cap $1.44B
Next Earnings
In 9 daysThu, May 7, 2026
EPS Estimate
-$0.35
4 analysts
Revenue Estimate
$52.43M
Last quarter: missed by -35.00% on EPS, -1.00% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$1.44B
P/E
—
Fwd P/E
88.25
P/S
5.30
Rev TTM
—
EPS TTM
-$0.16